INO·45773H409·US·equity·Healthcare - Biotechnology-13D/G
INO (INOVIO PHARMACEUTICALS INC) is held by 51 institutional investors as of Q4 2025. Largest holders: FMR LLC ($17.1M), JANUS HENDERSON GROUP PLC ($5.8M), VANGUARD GROUP INC ($5.8M). Net institutional sentiment: Mixed.
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer